Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 8, Pages 4623-4661
Publisher
American Chemical Society (ACS)
Online
2021-04-06
DOI
10.1021/acs.jmedchem.0c02094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction
- (2020) Dhulfiqar Ali Abed et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors
- (2020) Phillip R. Lazzara et al. ACS Medicinal Chemistry Letters
- An open-source drug discovery platform enables ultra-large virtual screens
- (2020) Christoph Gorgulla et al. NATURE
- Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
- (2020) Jesus M. Ontoria et al. ACS Medicinal Chemistry Letters
- ID30A-3 (MASSIF-3) – a beamline for macromolecular crystallography at the ESRF with a small intense beam
- (2020) David von Stetten et al. JOURNAL OF SYNCHROTRON RADIATION
- A CNS-targeting prodrug strategy for nuclear receptor modulators
- (2020) Skylar Ferrara et al. JOURNAL OF MEDICINAL CHEMISTRY
- A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions
- (2020) Mengchen Lu et al. Redox Biology
- Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
- (2020) Yi Sun et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors
- (2020) Hai-Shan Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions
- (2020) Meng-Chen Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction
- (2019) Tom D. Heightman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance–Based Fragment Screening
- (2019) Jonas Aretz et al. Frontiers in Chemistry
- Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity
- (2019) Meng-Chen Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity
- (2019) Kim T. Tran et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability
- (2019) Phillip R. Lazzara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Interaction Energetics and Druggability of the Protein–Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)
- (2019) Mengqi Zhong et al. BIOCHEMISTRY
- Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators
- (2019) Bin Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
- (2018) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- DIALS: implementation and evaluation of a new integration package
- (2018) Graeme Winter et al. Acta Crystallographica Section D-Structural Biology
- Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors
- (2018) Benjamin G. Richardson et al. JOURNAL OF MEDICINAL CHEMISTRY
- AceDRG: a stereochemical description generator for ligands
- (2017) Fei Long et al. Acta Crystallographica Section D-Structural Biology
- P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing
- (2017) Michele Cianci et al. JOURNAL OF SYNCHROTRON RADIATION
- Transcriptional Regulation by Nrf2
- (2017) Claudia Tonelli et al. ANTIOXIDANTS & REDOX SIGNALING
- Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
- (2016) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
- (2016) Madeline E. Kavanagh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening
- (2016) Renato Ferreira de Freitas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- Twenty years on: the impact of fragments on drug discovery
- (2016) Daniel A. Erlanson et al. NATURE REVIEWS DRUG DISCOVERY
- One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists
- (2015) Johannes Schiebel et al. ChemMedChem
- Evolutions in fragment-based drug design: the deconstruction–reconstruction approach
- (2015) Haijun Chen et al. DRUG DISCOVERY TODAY
- Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
- (2015) Atul D. Jain et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling
- (2015) Angelika F. Winkel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1–Nrf2 Protein–Protein Interaction
- (2015) Hélène C. Bertrand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand deconstruction: Why some fragment binding positions are conserved and others are not
- (2015) Dima Kozakov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation
- (2015) Mikiya Satoh et al. FEBS Open Bio
- Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
- (2014) Eric Jnoff et al. ChemMedChem
- Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
- (2014) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
- (2013) Douglas Marcotte et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Learning from our mistakes: The ‘unknown knowns’ in fragment screening
- (2013) Ben J. Davis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
- (2013) Longqin Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases
- (2013) Peter Canning et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
- (2013) Xinyuan Li et al. Journal of Hematology & Oncology
- Novel Pyridinone Derivatives As Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) with High Potency against NNRTI-Resistant HIV-1 Strains
- (2013) Amin Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The macromolecular crystallography beamline I911-3 at the MAX IV laboratory
- (2013) Thomas Ursby et al. JOURNAL OF SYNCHROTRON RADIATION
- Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1
- (2013) Toshiaki Fukutomi et al. MOLECULAR AND CELLULAR BIOLOGY
- The 'rule of three' for fragment-based drug discovery: where are we now?
- (2013) Harren Jhoti et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex
- (2013) L. Baird et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deconstruction of a Nutlin: Dissecting the Binding Determinants of a Potent Protein–Protein Interaction Inhibitor
- (2013) David C. Fry et al. ACS Medicinal Chemistry Letters
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Fragment-Based Approaches in Drug Discovery and Chemical Biology
- (2012) Duncan E. Scott et al. BIOCHEMISTRY
- ID29: a high-intensity highly automated ESRF beamline for macromolecular crystallography experiments exploiting anomalous scattering
- (2012) Daniele de Sanctis et al. JOURNAL OF SYNCHROTRON RADIATION
- Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
- (2012) Sadagopan Magesh et al. MEDICINAL RESEARCH REVIEWS
- Data processing and analysis with theautoPROCtoolbox
- (2011) Clemens Vonrhein et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Modeling Taylor dispersion injections: Determination of kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing
- (2011) John G. Quinn ANALYTICAL BIOCHEMISTRY
- Evaluation of Taylor dispersion injections: Determining kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing
- (2011) John G. Quinn ANALYTICAL BIOCHEMISTRY
- The cytoprotective role of the Keap1–Nrf2 pathway
- (2011) Liam Baird et al. ARCHIVES OF TOXICOLOGY
- ISPyB: an information management system for synchrotron macromolecular crystallography
- (2011) S. Delageniere et al. BIOINFORMATICS
- Stroke research at a crossroad: asking the brain for directions
- (2011) Costantino Iadecola et al. NATURE NEUROSCIENCE
- Optimization of data collection taking radiation damage into account
- (2010) Gleb P. Bourenkov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant
- (2010) Nicolas Basse et al. CHEMISTRY & BIOLOGY
- Fragment-Based Deconstruction of Bcl-xLInhibitors
- (2010) Sarah Barelier et al. JOURNAL OF MEDICINAL CHEMISTRY
- MxCuBE: a synchrotron beamline control environment customized for macromolecular crystallography experiments
- (2010) José Gabadinho et al. JOURNAL OF SYNCHROTRON RADIATION
- Iron-catalyzed selective reduction of nitro compounds to amines
- (2010) Leyla Pehlivan et al. TETRAHEDRON LETTERS
- Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
- (2009) Rao Muralikrishna Adibhatla et al. ANTIOXIDANTS & REDOX SIGNALING
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- EDNA: a framework for plugin-based applications applied to X-ray experiment online data analysis
- (2009) Marie-Françoise Incardona et al. JOURNAL OF SYNCHROTRON RADIATION
- Inflammatory mechanisms in ischemic stroke: therapeutic approaches
- (2009) Shaheen E Lakhan et al. Journal of Translational Medicine
- Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors
- (2008) Erik Lager et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fluorescence Spectroscopic Profiling of Compound Libraries
- (2008) Anton Simeonov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Surface Plasmon Resonance Based Assay for the Detection and Characterization of Promiscuous Inhibitors
- (2008) Anthony M. Giannetti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regioselective synthesis of sterically encumbered diaryl ethers based on one-pot cyclizations of 4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-dienes
- (2007) Muhammad A. Rashid et al. TETRAHEDRON
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started